heart failure
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) According to the diagnostic standard of Western medicine for heart failure; (2) NYHA class II-III cardiac function; (3) Aged 18-70 years old, male and female; (4) Those who voluntarily participated in the trial and signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) Late HF, moderate to severe aortic stenosis; (2) Uncontrolled arterial hypertension; (3) Patients with acute or chronic infection, advanced liver disease, end-stage chronic kidney disease or malignant disease; (4) Patients with oral iron (> 100mg / day), intravenous iron or erythropoietin, and non HF related anemia (such as hemoglobinopathy) in the past 6 weeks; (5) Patients with active bleeding or requiring blood transfusion and patients with known iron overload; (6) Participants in other drug trials within three months before screening; (7) According to the judgment of the researcher, it is not suitable for the participants.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin;Serum ferritin;Transferrin saturation;NT-proBNP;Interleukin-6;Interleukin-1;C-reactive protein;C-reactive protein; | — |
Secondary
| Measure | Time frame |
|---|---|
| creatinine;bilirubin; | — |
Countries
China
Contacts
Shanghai municipal Hospital of Traditional Chinese Medicine